JP2008543878A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008543878A5 JP2008543878A5 JP2008517207A JP2008517207A JP2008543878A5 JP 2008543878 A5 JP2008543878 A5 JP 2008543878A5 JP 2008517207 A JP2008517207 A JP 2008517207A JP 2008517207 A JP2008517207 A JP 2008517207A JP 2008543878 A5 JP2008543878 A5 JP 2008543878A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide agent
- use according
- terminal
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 22
- 239000003795 chemical substances by application Substances 0.000 claims 20
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- -1 DNaseI Proteins 0.000 claims 6
- 102000001708 Protein Isoforms Human genes 0.000 claims 6
- 108010029485 Protein Isoforms Proteins 0.000 claims 6
- 239000012736 aqueous medium Substances 0.000 claims 6
- 210000004899 c-terminal region Anatomy 0.000 claims 6
- 230000004410 intraocular pressure Effects 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- QQKKFVXSQXUHPI-NBVRZTHBSA-N Acidissiminol epoxide Chemical compound O1C(C)(C)C1CC(O)C(/C)=C/COC(C=C1)=CC=C1CCNC(=O)C1=CC=CC=C1 QQKKFVXSQXUHPI-NBVRZTHBSA-N 0.000 claims 3
- 108010038798 Actin Depolymerizing Factors Proteins 0.000 claims 3
- 102000015693 Actin Depolymerizing Factors Human genes 0.000 claims 3
- 108010063503 Actinin Proteins 0.000 claims 3
- 102000010825 Actinin Human genes 0.000 claims 3
- 101710138529 Depactin Proteins 0.000 claims 3
- 102000004878 Gelsolin Human genes 0.000 claims 3
- 108090001064 Gelsolin Proteins 0.000 claims 3
- 108050001408 Profilin Proteins 0.000 claims 3
- 102000011195 Profilin Human genes 0.000 claims 3
- FCHAMFUEENBIDH-UHFFFAOYSA-N Severin Natural products CC1CCC2C(C)C3CCC4(O)C(CC5C4CC(O)C6CC(CCC56C)OC(=O)C)C3CN2C1 FCHAMFUEENBIDH-UHFFFAOYSA-N 0.000 claims 3
- UGPMCIBIHRSCBV-XNBOLLIBSA-N Thymosin beta 4 Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(C)=O UGPMCIBIHRSCBV-XNBOLLIBSA-N 0.000 claims 3
- 102100035000 Thymosin beta-4 Human genes 0.000 claims 3
- 102000050760 Vitamin D-binding protein Human genes 0.000 claims 3
- 101710179590 Vitamin D-binding protein Proteins 0.000 claims 3
- 229940087051 fragmin Drugs 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 150000003462 sulfoxides Chemical class 0.000 claims 3
- 108010079996 thymosin beta(4) Proteins 0.000 claims 3
- 108090000195 villin Proteins 0.000 claims 3
- 208000010412 Glaucoma Diseases 0.000 claims 2
- 239000003246 corticosteroid Substances 0.000 claims 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69126105P | 2005-06-17 | 2005-06-17 | |
| US77694706P | 2006-02-28 | 2006-02-28 | |
| PCT/US2006/023759 WO2006138708A1 (en) | 2005-06-17 | 2006-06-19 | Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008543878A JP2008543878A (ja) | 2008-12-04 |
| JP2008543878A5 true JP2008543878A5 (enExample) | 2011-10-20 |
Family
ID=37570786
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517207A Pending JP2008543878A (ja) | 2005-06-17 | 2006-06-19 | 凍結乾燥したかまたは凍結乾燥させることができる形態であるlkktetおよび/またはlkktntペプチド組成物 |
| JP2008517208A Withdrawn JP2008543879A (ja) | 2005-06-17 | 2006-06-19 | Lkktetおよび/またはlkktntペプチド組成物ならびに方法 |
| JP2008517206A Pending JP2008543877A (ja) | 2005-06-17 | 2006-06-19 | Lkktetおよび/またはlkktnt組成物および組織の悪化、傷害または損傷を処置または予防するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517208A Withdrawn JP2008543879A (ja) | 2005-06-17 | 2006-06-19 | Lkktetおよび/またはlkktntペプチド組成物ならびに方法 |
| JP2008517206A Pending JP2008543877A (ja) | 2005-06-17 | 2006-06-19 | Lkktetおよび/またはlkktnt組成物および組織の悪化、傷害または損傷を処置または予防するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (8) | US20090131313A1 (enExample) |
| EP (4) | EP1904080A4 (enExample) |
| JP (3) | JP2008543878A (enExample) |
| KR (3) | KR20080018268A (enExample) |
| CN (1) | CN105106931A (enExample) |
| AU (3) | AU2006261155A1 (enExample) |
| CA (3) | CA2612405A1 (enExample) |
| HK (1) | HK1218248A1 (enExample) |
| IL (4) | IL187522A0 (enExample) |
| MX (3) | MX2007015956A (enExample) |
| WO (3) | WO2006138707A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010010177A (es) * | 2008-03-17 | 2012-08-23 | Regenerx Biopharmaceuticals | Fragmentos de beta timosina mejorada. |
| CN101297965B (zh) * | 2008-06-16 | 2011-01-05 | 浙江省中医药研究院 | 胸腺肽β4在制备防治支气管哮喘药物中的应用 |
| EP2485765A2 (en) | 2009-10-09 | 2012-08-15 | Board Of Regents The University Of Texas System | Photokinetic ocular drug delivery methods and apparatus |
| WO2012126047A1 (en) * | 2011-03-18 | 2012-09-27 | Adistem Ltd | Agent and method for treating pain and reducing inflammation |
| KR102038948B1 (ko) | 2012-03-01 | 2019-11-26 | 퍼스트스트링 리서치 인코포레이티드 | 알파 코넥신 c-말단 (act) 펩타이드를 포함하는 국소 겔 |
| EP2698162A1 (en) | 2012-08-15 | 2014-02-19 | Credentis AG | Method for producing a composition for treating a tooth lesion |
| TR201902755T4 (tr) * | 2013-11-07 | 2019-03-21 | Dr August Wolff Gmbh & Co Kg Arzneimittel | Depolama kararliliğina sahi̇p li̇yofi̇li̇ze tri̇pepti̇t formülasyonlari. |
| JP6612247B2 (ja) | 2014-03-12 | 2019-11-27 | ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン | 眼の感染症および疾患を処置するための組成物および方法 |
| US10406208B2 (en) | 2014-10-22 | 2019-09-10 | G-Treebnt Co., Ltd. | Composition containing thymosin beta 4, and pharmaceutical formulation comprising same |
| MA41299A (fr) * | 2014-12-30 | 2017-11-07 | Axim Biotechnologies Inc | Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite |
| KR20170021667A (ko) | 2015-08-18 | 2017-02-28 | 주식회사 지트리비앤티 | 티모신 β4를 유효성분으로 포함하는 신경영양성각막염 치료용 조성물 |
| US9867868B2 (en) * | 2015-08-18 | 2018-01-16 | G-Treebnt Co., Ltd. | Pharmaceutical composition for treating or preventing corneal wound comprising thymosin β4 and citric acid |
| KR102487614B1 (ko) | 2015-10-06 | 2023-01-12 | 에이치엘비테라퓨틱스 주식회사 | 티모신 β4를 포함하는 안약의 제조방법 |
| KR102488796B1 (ko) * | 2016-07-18 | 2023-01-13 | 리젠트리 엘엘씨 | 안구 건조증 치료 방법 |
| KR102115158B1 (ko) | 2016-11-29 | 2020-05-26 | 주식회사 지트리파마슈티컬 | 티모신 베타 4 를 함유하는 제형 |
| MX2019009759A (es) * | 2017-02-21 | 2020-07-27 | Tearsolutions Inc | Composiciones de peptido estables. |
| KR102340750B1 (ko) | 2017-03-03 | 2021-12-21 | 에이치엘비테라퓨틱스 주식회사 | 티모신 베타 4를 유효성분으로 포함하는 안정화된 외용 제제 |
| KR101910908B1 (ko) * | 2017-06-14 | 2018-10-24 | (주)휴온스 | Gly-Tβ4 (Gly-티모신β4)을 함유하는 안구건조증 치료용 약학적 조성물 |
| US10342824B2 (en) | 2017-07-17 | 2019-07-09 | Dr. Marlowe's Weight Loss Institute, P.L.L.C. | Supplement for treating side effects of medications which cause metabolic acidosis |
| US20200353052A1 (en) * | 2017-11-24 | 2020-11-12 | G-Treebnt Co., Ltd. | Composition for promoting goblet cell proliferation or mucin secretion comprising thymosin beta 4 or derivative thereof as active ingredient |
| MX2023004631A (es) | 2020-10-22 | 2023-07-20 | Xequel Bio Inc | Formulaciones peptidicas y usos oftalmicos de las mismas. |
| CN119730839A (zh) * | 2022-07-01 | 2025-03-28 | 缇尔索卢森公司 | 稳定的肽组合物及使用其治疗中/重度干眼相关的眼部症状的方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444757A (en) * | 1981-11-16 | 1984-04-24 | Research Corporation | Use of thymosin as an anti-diabetes and anti-hypertensive disease agent |
| US4906613A (en) | 1985-11-05 | 1990-03-06 | Schering Corporation | Antiglaucoma compositions and methods |
| NZ235556A (en) | 1986-11-05 | 1991-06-25 | Ethicon Inc | Breast milk substitute containing recombinant human egf |
| FR2647675B1 (fr) | 1989-06-05 | 1994-05-20 | Sanofi | Utilisation d'un derive de la statine dans le traitement des affections oculaires |
| US5564345A (en) * | 1993-05-11 | 1996-10-15 | Park Ohio Industries Inc. | Stackable table, table assembly, and tray and table combination |
| DK0639070T4 (da) * | 1992-05-06 | 2010-12-13 | Alcon Lab Inc | Anvendelse af borat-polyolkomplekser til ophtalmiske præparater |
| US5578570A (en) * | 1993-10-07 | 1996-11-26 | The George Washington University Medical Center | Method of treating septic shock using thymosin β4 |
| US5593964A (en) * | 1993-10-07 | 1997-01-14 | The George Washington University Medical Center | Method of treating septic shock by preventing actin polymerization |
| WO1996003158A1 (en) | 1994-07-22 | 1996-02-08 | Alcon Laboratories, Inc. | Use of low molecular weight amino acids in ophthalmic compositions |
| GB9806632D0 (en) | 1998-03-28 | 1998-05-27 | Stevenson Robert | Peptide factor |
| US20040131626A1 (en) * | 2001-03-15 | 2004-07-08 | Goldstein Allan L. | Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
| EP1591128A1 (en) * | 1998-07-30 | 2005-11-02 | The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health | Thymosin beta 4 promotes wound repair |
| US7273618B2 (en) * | 1998-12-09 | 2007-09-25 | Chiron Corporation | Method for administering agents to the central nervous system |
| WO2002024234A2 (en) * | 2000-09-20 | 2002-03-28 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| JP2005502672A (ja) * | 2001-08-29 | 2005-01-27 | リジェナークス・バイオファーマスーティカルズ・インコーポレイテッド | サイモシンβ4、類似体、アイソフォームおよびその他の誘導体を用いて心筋障害の発生前、発生中または発生後に発生する炎症、損傷およびその他の変化を治癒または予防する方法 |
| US20040005644A1 (en) * | 2002-02-28 | 2004-01-08 | Su Yan A. | Method and composition for detection and treatment of breast cancer |
| AU2003278727A1 (en) * | 2002-09-20 | 2004-04-08 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
| US20060263360A1 (en) | 2003-03-31 | 2006-11-23 | Regenerx Biopharmaceuticals, Inc. | Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| WO2004099768A1 (en) * | 2003-05-05 | 2004-11-18 | Regenerx Biopharmaceuticals, Inc. | Method for detecting development of a physiological disorder in a subject |
| KR102632066B1 (ko) | 2015-07-30 | 2024-02-02 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 발광 장치의 제작 방법, 발광 장치, 모듈, 및 전자 기기 |
-
2006
- 2006-06-19 JP JP2008517207A patent/JP2008543878A/ja active Pending
- 2006-06-19 JP JP2008517208A patent/JP2008543879A/ja not_active Withdrawn
- 2006-06-19 MX MX2007015956A patent/MX2007015956A/es not_active Application Discontinuation
- 2006-06-19 AU AU2006261155A patent/AU2006261155A1/en not_active Abandoned
- 2006-06-19 EP EP06785091A patent/EP1904080A4/en not_active Withdrawn
- 2006-06-19 EP EP17204441.4A patent/EP3326647A1/en not_active Ceased
- 2006-06-19 WO PCT/US2006/023758 patent/WO2006138707A1/en not_active Ceased
- 2006-06-19 CN CN201510532998.4A patent/CN105106931A/zh active Pending
- 2006-06-19 KR KR1020087000980A patent/KR20080018268A/ko not_active Withdrawn
- 2006-06-19 US US11/917,869 patent/US20090131313A1/en not_active Abandoned
- 2006-06-19 WO PCT/US2006/023760 patent/WO2006138709A2/en not_active Ceased
- 2006-06-19 CA CA002612405A patent/CA2612405A1/en not_active Abandoned
- 2006-06-19 KR KR1020087000983A patent/KR20080021782A/ko not_active Withdrawn
- 2006-06-19 CA CA002612410A patent/CA2612410A1/en not_active Abandoned
- 2006-06-19 US US11/917,883 patent/US20080214456A1/en not_active Abandoned
- 2006-06-19 EP EP06785092A patent/EP1906986A4/en not_active Ceased
- 2006-06-19 AU AU2006261157A patent/AU2006261157A1/en not_active Abandoned
- 2006-06-19 MX MX2007015957A patent/MX2007015957A/es active IP Right Grant
- 2006-06-19 JP JP2008517206A patent/JP2008543877A/ja active Pending
- 2006-06-19 MX MX2007015958A patent/MX2007015958A/es not_active Application Discontinuation
- 2006-06-19 AU AU2006261156A patent/AU2006261156B2/en not_active Ceased
- 2006-06-19 EP EP06785093A patent/EP1896050A4/en not_active Withdrawn
- 2006-06-19 CA CA002612522A patent/CA2612522A1/en not_active Abandoned
- 2006-06-19 WO PCT/US2006/023759 patent/WO2006138708A1/en not_active Ceased
- 2006-06-19 US US11/917,848 patent/US8383576B2/en not_active Expired - Fee Related
- 2006-06-19 KR KR1020087000982A patent/KR20080033939A/ko not_active Ceased
-
2007
- 2007-11-20 IL IL187522A patent/IL187522A0/en unknown
- 2007-11-25 IL IL187617A patent/IL187617A0/en unknown
- 2007-11-29 IL IL187781A patent/IL187781A/en active IP Right Grant
-
2011
- 2011-08-26 US US13/219,394 patent/US9821030B2/en active Active
-
2012
- 2012-03-06 IL IL218504A patent/IL218504A/en active IP Right Grant
-
2016
- 2016-01-19 US US15/000,297 patent/US9585941B2/en active Active
- 2016-06-01 HK HK16106215.8A patent/HK1218248A1/zh unknown
- 2016-06-15 US US15/183,334 patent/US20160287673A1/en not_active Abandoned
-
2017
- 2017-01-24 US US15/414,014 patent/US20170128540A1/en not_active Abandoned
- 2017-10-12 US US15/782,293 patent/US10004785B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008543878A5 (enExample) | ||
| US11911447B2 (en) | Peptide pharmaceuticals for insulin resistance | |
| AU634954B2 (en) | Treatment of diabetes mellitus | |
| KR102255479B1 (ko) | 인슐린 저항성에 대한 개선된 펩티드 제약 | |
| US20200289653A1 (en) | Improved peptide pharmaceuticals for insulin resistance | |
| CN102292346B (zh) | 肥胖的治疗 | |
| KR102542164B1 (ko) | 인슐린 저항성에 대한 개선된 펩티드 약제 | |
| CA2698582A1 (en) | Peptide having an extending action for half-life of object peptide in plasma | |
| KR20240128130A (ko) | 펩티드 wkdeagkplvk를 포함하는 조성물 | |
| CN116322739A (zh) | Glp-1r激动剂/fgf21融合蛋白 | |
| CN110300595A (zh) | Pac1受体激动剂(maxcap)及其用途 | |
| CN103391786B (zh) | 作为抗糖尿病肽的载脂蛋白a-iv | |
| US20200172587A1 (en) | Hydrochloride salts of c5a receptor agonist peptides | |
| JP3260760B2 (ja) | ヒルジンを含んでなる医薬組成物 | |
| CN116113639A (zh) | 活性降低的glp-1r激动肽 | |
| JP3350604B2 (ja) | ヒルジン含有医薬組成物 | |
| CN104592380A (zh) | 一种多肽、多肽衍生物、多肽的可药用盐、药物组合物及其应用 | |
| WO2018188565A1 (zh) | 用于治疗代谢系统疾病的多肽及其组合物 | |
| WO2017121764A1 (en) | Pharmaceutical formulations for the treatment of diabetes | |
| JP2017532292A (ja) | ミリストイル化レプチン関連ペプチド及びその使用 | |
| WO2024234320A1 (zh) | 一种长效胰高血糖素样肽-1衍生物及其制备方法和用途 | |
| US20210171604A1 (en) | Peptides for the treatment of type 2 diabetes |